首页> 外文期刊>Haemophilia: the official journal of the World Federation of Hemophilia >Predictors of non-adherence to prescribed prophylactic clotting-factor treatment regimens among adolescent and young adults with a bleeding disorder
【24h】

Predictors of non-adherence to prescribed prophylactic clotting-factor treatment regimens among adolescent and young adults with a bleeding disorder

机译:在出血性疾病的青少年中不遵守处方的预防性凝血因子治疗方案的预测因素

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Adherence to clotting-factor treatment regimens, especially among adolescents and young adults (AYAs), is under-researched. Aim: We determined factors associated with better adherence to prophylaxis. Methods: From April through December 2012, a convenience sample of AYA (aged 13-25 years) persons with haemophilia or von Willebrand disease (VWD) completed an online survey that assessed adherence to prescribed prophylactic treatment regimens [Validated Haemophilia Regimen Treatment Adherence Scale (VERITAS)-Pro]. Logistic regression analysis assessed demographic and clinical factors related to non-adherence (VERITAS-Pro >= 57). Results: Seventy-three prophylactically treating AYAs participated. Of which, 88%, 8% and 4% had haemophilia A, B and VWD respectively. Almost all (90%) had severe disease and 58% had never developed an inhibitor. Most were aged 13-17 years (56%), white (78%), non-Hispanic (88%), never married (94%) and had some type of health insurance (96%). Median VERITAS-Pro score was 48 (range = 25-78) and 22 (30%) participants were non-adherent to prophylaxis (VERITAS-Pro= 57). Final logistic regression modelling suggested that, compared to those aged 13-17 years, participants aged 18-25 years were 6.2 (95% CI: 1.8-21.0; P < 0.01) times more likely to be non-adherent. Compared to respondents whose mother had at least a Bachelor's degree, respondents whose mother did not were 3.8 (95% CI: 1.0-14.3; P = 0.05) times more likely to be non-adherent. Conclusions: Results suggest that adherence efforts should be especially targeted to young adults as they transition from adolescence (i.e. parental supervision) and assume primary responsibility for their bleeding disorder care. Healthcare providers should be mindful of AYAs whose mothers have less formal education and ensure that adequate time and resources are dedicated to family adherence education.
机译:简介:对凝血因子治疗方案的依从性,尤其是在青少年和年轻人中的研究仍在研究中。目的:我们确定了与预防的依从性更好相关的因素。方法:从2012年4月至2012年12月,对AYA(13-25岁)血友病或von Willebrand病(VWD)患者的便利性样本完成了一项在线调查,评估了对规定的预防性治疗方案的依从性[验证的血友病治疗方案依从性量表( VERITAS)-Pro]。 Logistic回归分析评估了与不依从相关的人口统计学和临床​​因素(VERITAS-Pro> = 57)。结果:参加了73例预防性AYA治疗。其中,分别有88%,8%和4%的血友病患者患有甲型血友病。几乎所有患者(90%)都患有严重疾病,而58%的患者从未开发过抑制剂。多数年龄在13-17岁之间(56%),白人(78%),非西班牙裔(88%),从未结婚(94%)并拥有某种健康保险(96%)。 VERITAS-Pro得分中位数为48(范围= 25-78),而22位参与者(30%)对预防没有坚持(VERITAS-Pro = 57)。最终的逻辑回归模型表明,与13-17岁的参与者相比,18-25岁的参与者不依从的可能性高6.2倍(95%CI:1.8-21.0; P <0.01)。与母亲至少具有学士学位的受访者相比,母亲没有依恋者的可能性高3.8倍(95%CI:1.0-14.3; P = 0.05)倍。结论:结果表明,依从性工作应特别针对年轻人,因为他们从青春期过渡(即父母监护)并承担其对出血性疾病的主要责任。医疗保健提供者应注意其母亲受正规教育较少的AYA,并确保有足够的时间和资源用于家庭依从性教育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号